AZYO
Aziyo Biologics, Inc.
NASDAQHealthcareMedical - DevicesUS
Company Profile
CEO
C. Randal Mills
IPO Date
2020-10-08
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Country
US
Aziyo Biologics, Inc.
CEO
C. Randal Mills
IPO Date
2020-10-08
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Country
US
| 2,154,116 |
| $1.43 |
| 5 Oct 2023 | HighCape Capital, L.P. | director, 10 percent owner: | P-Purchase | Acquired | 2,837,128 | $1.43 |
| 5 Oct 2023 | HighCape Capital, L.P. | director, 10 percent owner: | P-Purchase | Acquired | 4,255,693 | $1.43 |
| 21 Sept 2023 | Ferguson Matthew | CHIEF FINANCIAL OFFICER | A-Award | Acquired | 70,053 | $1.43 |
| 21 Sept 2023 | Ferguson Matthew | CHIEF FINANCIAL OFFICER | A-Award | Acquired | 105,080 | $1.43 |
| 23 Jun 2023 | Mills C Randal | director, officer: PRESIDENT AND CEO | M-Exempt | Acquired | 22,474 | $0.00 |
| 23 Jun 2023 | Mills C Randal | director, officer: PRESIDENT AND CEO | M-Exempt | Disposed | 22,474 | $0.00 |
| 23 Jun 2023 | Mills C Randal | director, officer: PRESIDENT AND CEO | F-InKind | Disposed | 7,772 | $2.41 |
| 12 Jun 2023 | Jordan Maybelle | director | A-Award | Acquired | 25,000 | $2.37 |